Publication | Closed Access
Angiotensin II up‐regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor
25
Citations
28
References
2009
Year
Therefore, PAX2 may be a novel therapeutic target for the treatment of carcinomas such as prostate cancer via the down-regulation of its expression by targeting the AT1R signaling pathways.
| Year | Citations | |
|---|---|---|
Page 1
Page 1